课题基金 / 基金详情

2006 Gordon Research Conference on Hemostasis

2006 Gordon Research Conference on Hemostasis
2006 年戈登止血研究会议
批准号:
7113337
负责人:
Jose Aron Lopez
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30

项目摘要

项目成果

Jose Aron Lopez的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供): 本申请寻求对戈登止血会议的部分支持,该会议将于7月9日至14日在缅因州沃特维尔的科尔比学院举行。这个戈登会议系列成立于1973年,现在每两年举行一次。2002年和2004年的会议也都在科尔比学院举行,在实现其科学目标和吸引充分订阅会议方面都非常成功。来自学术界、政府和工业界的190多名科学家申请了戈登会议组织允许的135个名额,我们最终获准容纳152名与会者。与会者的评价一致是积极的。为2006年会议组织了一个由37名杰出发言人组成的方案。这些演讲者将提供关于止血主要主题的最新讲座,包括凝血,抗凝,血小板粘附,ADAMTS-13和TTP,血小板信号传导和膜微泡生物学。这些都是该领域的热门领域。发言者将被鼓励提出最高水平的未发表的工作。与以往一样,这些发言无疑将激发热烈和富有煽动性的讨论;每次发言后都留出了充足的时间进行这种讨论。会议领导人(尚待确定)将领导和集中这些讨论,并鼓励广大听众参与。沿着上述会议,将组织一个“热点问题”。这将包括从提交的摘要中选出的简短介绍,并将向工作组通报最新信息。海报会议,在会议的5天中的4天举行,将补充该计划。根据过去的经验,我们预计大约有50张海报。会议将在戈登会议网站和科学期刊上公布。与会者将从网上提交的申请中选出;我们将通过积极寻求妇女和代表性不足的少数民族作为发言人,会议主席,海报和摘要演示者以及与会者来寻求平衡的代表性。止血戈登会议一直是一个非常成功和愉快的会议,经常被确定为与会者参加的最好的会议;我们相信,目前的计划有潜力扩大这一传统。
英文摘要
DESCRIPTION (provided by applicant): This application seeks partial support for the Gordon Conference on Hemostasis, to be held July 09-14 at Colby College in Waterville, Maine. This Gordon Conference series was founded in 1973 and is now held biennially. The 2002 and 2004 meetings were both also held at Colby College, and were highly successful, in terms of both attaining its scientific objectives and attracting a fully subscribed meeting. More than 190 scientists from academic, government and industry applied for the 135 slots permitted by the Gordon Conference Organization, and we were ultimately allowed to accommodate 152 attendees. The evaluations by participants were uniformly positive. A program of 37 outstanding speakers has been organized for the 2006 conference. These speakers will provide state-of-the-art lectures on the major topics of hemostasis, including coagulation, anticoagulation, platelet adhesion, ADAMTS-13 and TTP, platelet signaling, and the biology of membrane microvesicles. These are highly topical areas in the field. Speakers will be encouraged to present unpublished work of the highest caliber. As they have in the past, these presentations will undoubtedly spur lively and provocative discussion; ample time has been set aside after each presentation for such discussion. Session leaders, still to be identified, will lead and focus these discussions and will encourage broad audience participation. Along with the sessions mentioned above, a "Hot topics" will be organized. This will comprise short presentations, which are to be selected from submitted abstracts, and will serve to inform the group of latest-breaking information. Poster sessions, held on 4 of the 5 days of the meeting, will complement the program. Based on past experience, we can anticipate approximately 50 posters. The meeting will be publicized on the Gordon Conference Web and in scientific journals. Participants will be selected from applications submitted on-line; we will seek to a balanced representation by actively seeking women and under-represented minorities as speakers, session chairs, poster and abstract presenters, and attendees. The Hemostasis Gordon Conference has been a highly successful and enjoyable meeting, frequently identified as the best meeting attended by participants; and we believe that the current program has the potential to extend this tradition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of sialoglycan binding in the pathogenesis of streptococcal endocarditis
  • 批准号:
    10714047
  • 项目类别:
  • 资助金额:
    $80.67万
  • 财政年份:
    2023
  • 负责人:
    Jose Aron Lopez
  • 依托单位:
Molecular and Translational Studies in Hematologic Disorders
  • 批准号:
    10379456
  • 项目类别:
  • 资助金额:
    $108.1万
  • 财政年份:
    2019
  • 负责人:
    Jose Aron Lopez
  • 依托单位:
Molecular and Translational Studies in Hematologic Disorders
  • 批准号:
    10593910
  • 项目类别:
  • 资助金额:
    $108.01万
  • 财政年份:
    2019
  • 负责人:
    Jose Aron Lopez
  • 依托单位:
Molecular and Translational Studies in Hematologic Disorders
  • 批准号:
    9894847
  • 项目类别:
  • 资助金额:
    $108.46万
  • 财政年份:
    2019
  • 负责人:
    Jose Aron Lopez
  • 依托单位: